Executives On The Move
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.

Executives On The Move: New Hires At Ipsen, Decibel Therapeutics and Reata Pharmaceuticals
Recent executive moves in the industry include new C-suite hires at Editas Medicines, Royalty Pharma and Faron Pharmaceuticals.

Executives On The Move: C-Suite Changes At ImmunoGen, Kronos Bio, Verve Therapeutics And More
Recent executive moves in the industry include new CEOs at Rentschler Biopharma, MedinCell and OncoZenge, plus C-suite changes at Hinova Pharmaceuticals and ImmunoGen.

GSK Reorganizes Around Key R&D Areas As Lepore Exits
The UK-based company has replaced its single head of research with four therapy area-focused leaders as it looks to further boost R&D productivity.

Executives On The Move: 12 New CEOs and 10 New CFOs
Recent executive moves in the industry include new CEOs at Baxter BioPharma Solutions, Destiny Pharma and PAION, while Medicenna Therapeutics, Mirum Pharmaceuticals and Scancell, among others, get new CFOs.

Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: the rise of Novo Nordisk; senior level changes at Novartis; Moderna’s progress against BA.2.86; major new CNS drugs coming; and Boehringer Ingelheim’s head of innovation on R&D priorities.

Executives On The Move: Exelixis, Design Therapeutics And More
Recent executive moves in the industry include C-suite changes at Abivax, Innoviva and VistaGen Therapeutics, plus a new CMO at Exelixis.

Executives On The Move: PaxMedica, Aurinia and More
Recent executive moves in the industry include C-suite changes at PaxMedica and Amicus Therapeutics. Meanwhile, new directors were appointed at Aurinia Pharmaceutical and Skye Bioscience.

Executives On The Move: Eterna, Syncom and More
Recent executive moves in the industry include C-suite changes at Eterna Therapeutics and PaxMedica. Meanwhile, new directors were appointed at Syncom Formulation and Soleno Therapeutics.

Executives On The Move: Mirati Therapeutics, Spero Therapeutics And More
Recent executive moves in the industry include C-suite changes at Mirati Therapeutics, Spero Therapeutics and Verastem. Meanwhile, new directors were appointed at Xenon Pharmaceuticals, MediciNova and Allarity Therapeutics.

Will More Indian Family-Owned Firms Hand Over The Baton To PEs?
Private equity firms are among those believed to be in the fray for a stake in India's Cipla, a company with a rich legacy and steeped in history. It’s an ideal case study for buyout funds, an investment banker tells Scrip.

Executives On The Move: GreenLight, Kiromic and More
Recent executive moves in the industry include C-suite changes at GreenLight Biosciences Holdings and TScan Therapeutics. Meanwhile, new directors were appointed at AEON Biopharma and Kiromic Biopharma.

Executives On The Move: Amarin, Shanghai Henlius, AI Therapeutics and More
Recent executive moves in the industry include C-suite changes at Amarin, Shanghai Henlius Biotech and Futura Medical. Meanwhile, new directors were appointed at AI Therapeutics and Arbutus Biopharma.

Executives On The Move: BioCryst, Abivax and More
Recent executive moves in the industry include C-suite changes at BioCryst Pharmaceuticals and CytoDyn. Meanwhile, new directors were appointed at Abivax and Eterna Therapeutics.

Executives On The Move: Bionomics, Kineta and More
Recent executive moves in the industry include C-suite changes at Bionomics and Kancera. Meanwhile, new directors were appointed at Kineta and NLS Pharmaceuticals.

Executives On The Move: Ferring, Acorda and More
Recent executive moves in the industry include C-suite changes at Windtree Therapeutics and Ferring, plus new board members at Acorda Therapeutics and Mirati Therapeutics.

Executives On The Move: Pharnext, Prometheus Biosciences And More
Recent executive moves in the industry include C-suite changes at Everest Medicines, Pharnext and Cerevel Therapeutics, plus new board members at Arvinas and Prometheus Biosciences.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.